Clinical trial
A Phase 3, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
NCT06029426 is registered in ClinicalTrials.gov with Neumora Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
- Lead sponsor
- Neumora Therapeutics, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 20, 2023
- Completion date
- January 15, 2025
- Enrollment
- 383 (actual)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.